Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to investigate the relationship between immune checkpoint inhibitors and various autoimmune bullous diseases.
Review of cases related to immune checkpoint inhibitor use and autoimmune bullous diseases.
Focus on conditions beyond bullous pemphigoid.
Analysis of clinical manifestations and treatment responses.
Identified several autoimmune bullous conditions associated with immune checkpoint inhibitors.
Confirmed the prevalence of these conditions beyond just bullous pemphigoid.
Noted variations in treatment responses and clinical outcomes among affected individuals.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

This analysis explores autoimmune bullous diseases linked to immune checkpoint inhibitors, suggesting new considerations for treatment.

No takes yet. Share an insight, caveat, or question.

Koumprentziotis et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share